Suppression of telomerase activity and cytokine messenger RNA levels in acute myelogenous leukemia cells in vivo in patients by amifostine and interleukin 4.

Preisler, H D; Li, B; Yang, B L; Huang, R W; Devemy, E; Venugopal, P; Tao, M; Chopra, H; Gregory, S A; Adler, S; Sivaraman, S; Toofanfard, P; Jajeh, A; Galvez, A; Robin, E

Preisler, H D; Li, B; Yang, B L; Huang, R W; Devemy, E; Venugopal, P; Tao, M; Chopra, H; Gregory, S A; Adler, S; Sivaraman, S; Toofanfard, P; Jajeh, A; Galvez, A; Robin, E.

Affiliation

Preisler HD; Department of Medicine, Rush Cancer Institute, Chicago, Illinois 60612, USA.

Clin Cancer Res ; 6(3): 807-12, 2000 Mar.

Article in En | MEDLINE | ID: mdl-10741700

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: RNA, Messenger / Leukemia, Myeloid, Acute / Cytokines / Interleukin-4 / Amifostine / Telomerase Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2000 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links